Interpace Biosciences, Inc. (IDXGD)
7.618
+0.37
(+5.08%)
USD |
OTCM |
Aug 28, 16:00
Interpace Biosciences Price : 7.618 for Aug. 28, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | 6.50 | 7.80 | 6.50 | 7.618 | 2520.00 |
| Aug 26, 2026 | 7.10 | 7.85 | 7.10 | 7.25 | 1421.00 |
| Aug 25, 2026 | 7.05 | 7.26 | 6.55 | 7.10 | 1300.00 |
| Aug 24, 2026 | 7.188 | 7.25 | 7.125 | 7.15 | 403.00 |
| Aug 21, 2026 | 7.55 | 7.712 | 7.05 | 7.614 | 1966.00 |
| Aug 20, 2026 | 7.90 | 8.148 | 7.90 | 8.05 | 5961.00 |
| Aug 19, 2026 | 7.925 | 7.925 | 7.85 | 7.85 | 70.00 |
| Aug 18, 2026 | 8.20 | 8.20 | 7.95 | 8.00 | 1382.00 |
| Aug 17, 2026 | 8.25 | 8.50 | 8.15 | 8.50 | 1827.00 |
| Aug 14, 2026 | 8.35 | 8.50 | 8.00 | 8.30 | 4341.00 |
| Aug 13, 2026 | 8.35 | 8.425 | 8.15 | 8.35 | 4845.00 |
| Aug 12, 2026 | 8.35 | 8.35 | 8.20 | 8.35 | 421.00 |
| Aug 11, 2026 | 8.30 | 8.50 | 8.30 | 8.345 | 3650.00 |
| Aug 10, 2026 | 8.20 | 8.50 | 8.20 | 8.50 | 2741.00 |
| Aug 07, 2026 | 8.05 | 8.05 | 8.05 | 8.05 | 100.00 |
| Aug 06, 2026 | 7.90 | 8.208 | 7.70 | 8.20 | 260.00 |
| Aug 05, 2026 | 7.25 | 7.488 | 7.25 | 7.488 | 203.00 |
| Aug 04, 2026 | 7.25 | 8.15 | 7.05 | 8.15 | 821.00 |
| Aug 03, 2026 | 7.20 | 7.95 | 7.20 | 7.95 | 380.00 |
| Jul 31, 2026 | 7.585 | 7.585 | 7.585 | 7.585 | 20.00 |
| Jul 30, 2026 | 7.168 | 7.20 | 7.168 | 7.20 | 82.00 |
| Jul 29, 2026 | 7.75 | 7.758 | 7.75 | 7.758 | 60.00 |
| Jul 28, 2026 | 7.55 | 7.762 | 7.55 | 7.762 | 340.00 |
| Jul 27, 2026 | 7.45 | 7.723 | 7.45 | 7.723 | 64.00 |
| Jul 24, 2026 | 7.25 | 7.30 | 7.204 | 7.30 | 800.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Exlites Holdings International, Inc. | 0.35 |
| Xcelerate, Inc. | 0.0110 |
| Vivos Therapeutics, Inc. | 0.2249 |
| Hinge Health, Inc. | 87.35 |
| PD-Rx Pharmaceuticals, Inc. | 3.10 |
Price Related Metrics
| PE Ratio | 1.727 |
| PS Ratio | 1.168 |
| PEG Ratio | 0.0397 |
| Price to Book Value | 1.816 |
| Price to Free Cash Flow | 10.29 |
| Earnings Yield | 57.91% |
| Market Cap | 42.21M |
| PEGY Ratio | 0.0397 |
| Operating PE Ratio | 10.13 |
| Normalized PE Ratio | 1.732 |